Why is Vivo Bio Tech falling/rising?

As of 24-Jul, Vivo Bio Tech Ltd. is currently priced at 35.50, reflecting a slight increase of 0.03 or 0.08%. The stock has been gaining over the last two days, with a total return of 1.08% during this period. However, it has underperformed its sector by 0.27% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -6.08%, while its profits have risen significantly by 187.8%, indicating a discrepancy between stock performance and underlying profitability. Additionally, the promoter holding has decreased to 39.06%, which may signal concerns among investors regarding the company's long-term stability.
In the broader market context, Vivo Bio Tech's short-term performance contrasts with the Sensex, which has shown a slight decline of 0.09% over the past week. While the stock has experienced a minor uptick recently, its overall performance remains weak, with a -4.77% return year-to-date compared to the Sensex's gain of 5.18%. This underperformance is compounded by weak long-term fundamentals, including a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio of 1.99, suggesting challenges in servicing debt. Overall, despite some recent gains, the stock's long-term outlook appears concerning, leading to a cautious sentiment among investors.